Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.
暂无分享,去创建一个
A. C. Dubbelman | H. Rosing | J. Beijnen | H. Pinedo | J H Beijnen | I. Mandjes | M. Huizing | W. W. ten Bokkel Huinink | H Rosing | H M Pinedo | M T Huizing | A C Keung | V van der Kuij | W W ten Bokkel Huinink | I M Mandjes | A C Dubbelman | A. Keung | V. van der Kuij
[1] A. Einzig,et al. Phase II trial of taxol in patients with metastatic renal cell carcinoma. , 1991, Cancer investigation.
[2] F. Ognibene,et al. Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] G. Cragg,et al. Metabolism of plant-derived anticancer agents. , 1988, Pharmacology & therapeutics.
[4] B. Monsarrat,et al. Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[5] D. Ettinger,et al. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. , 1989 .
[6] J. Willson,et al. Phase I study of taxol administered as a short i.v. infusion daily for 5 days. , 1987, Cancer treatment reports.
[7] R. Donehower,et al. Taxol: a novel investigational antimicrotubule agent. , 1990, Journal of the National Cancer Institute.
[8] D. Ettinger,et al. Phase I and pharmacodynamic study of taxol in refractory acute leukemias. , 1989, Cancer research.
[9] J. Koeller,et al. A phase I trial of taxol given by a 6-hour intravenous infusion. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] R. Lipton,et al. Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] L. Grochow,et al. Phase I trial of taxol in patients with advanced cancer. , 1987, Cancer treatment reports.
[12] S. Legha,et al. Phase I study of taxol using a 5-day intermittent schedule. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Horwitz,et al. Mechanism of action of taxol. , 1992, Trends in pharmacological sciences.
[14] E K Rowinsky,et al. Sequences of taxol and cisplatin: a phase I and pharmacologic study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Proost,et al. MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. , 1992, Computers in biology and medicine.
[16] L. Grochow,et al. High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial. , 1987, Cancer treatment reports.
[17] R. Lipton,et al. Phase I clinical and pharmacokinetic study of taxol. , 1987, Cancer research.
[18] Cragg Gm,et al. Taxol: the supply issue. , 1991 .
[19] C. Runowicz,et al. Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.